Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Genepro Gen2 Absorption and Protein Value Clinical Trial.
Objective: To prove the absorbability and usability of Genepro Gen2 Protein and compared to whey isolate. This study is intended to show the equivalent value of Genepro Gen2 as compared to whey protein isolate (1 tablespoon Genepro Gen2 compared to 30g serving of whey isolate)
Parameters: This study encompasses a 12-week program that follows 20 gastric bypass patients that have undergone weight loss surgery. We took a baseline blood analysis prior to the start of the study and subsequently we took weekly blood work to chart and register the findings. For this study we will only be doing the weekly analysis on blood protein levels by utilizing Spectrophotometry. The target blood protein range is 6.1-8.7 g/dL this test is administered while fasting.
Participants: 20 Post Op Gastric Bypass patients. 10 men, 10 women. All participants were between the ages of 30-46 years of age. All participants have been post operation from their weight loss surgery for a minimum of 3 months prior to the start of the study and no longer than 12 months at the start of the study.
Gathering Results: 10 subjects will receive Genepro Gen 2 protein (1 tablespoon serving) for the first 6 weeks of the study and for the last six weeks, they will receive 30g of Whey protein. In conjunction the other group of 10 subjects will receive 30g whey protein the first 6 weeks of the study and Genepro Gen2 protein the final six weeks. Weekly blood analysis will determine blood protein levels.
Diet: Diet guidelines limit the calories you consume while providing you with balanced meals to help prevent nutritional deficiencies and preserve your muscle tissue. Each patient tolerates suggested foods differently.
Daily calories should be between 600 to 700 for the duration of this study. Each subject is to follow a diet low in calories, fats and sweets. The goal for each subject is to consume a minimum of 65 to 75 grams of protein a day. High protein foods include eggs, meats, fish, seafood, tuna, poultry, tofu, milk, soy, cottage cheese, and yogurt. 30g of each daily intake of protein will be provided by a powdered protein supplement. Each subject will utilize a 30g serving of whey isolate for 6 weeks of their study and for the other 6 weeks the subject will use a single serving (1tablespoon) of Genepro Gen2 Protein.
Subject were given the following eating guidelines:
Exercise: Each subject is asked to exercise for 30 to 45 minutes a day, with cardio or aerobic activity three to five times a week. Initially, we recommend walking five minutes in the morning and five minutes in the late afternoon. As tolerated you should increase these intervals by five minutes until you are walking at least 15 minutes twice per day.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Genepro Gen2 Protein | Active Comparator | 1 tablespoon Serving of Genepro Gen2 Protein daily will be used in each subject. Intervention: Weekly blood draws will determine the effect on blood protein levels. |
|
| Whey Protein Isolate | Active Comparator | 30g Serving of Whey Isolate Protein will be used daily in each subject. Intervention: Weekly blood draws will determine the effect on blood protein levels. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Genepro Protein | Dietary Supplement | weekly blood draws to measure blood protein levels |
|
| Measure | Description | Time Frame |
|---|---|---|
| Weekly Blood Draws to Measure Blood Protein Levels | Each week the 20 participants will have blood drawn to measure their blood protein levels. Each participant was required to give blood weekly to determine the blood protein levels. The results show the average over each six week period of testing for each row. Each participant was examined to see if they achieved the average range as set fourth by the dieticians of greater than 6.1 and less than 8.7 within a 10% variable as acceptable. 10 Participants will be given Genepro Gen2 for the first six weeks of the study and whey protein for the final 6. 10 Participants will be given when protein for the first six weeks of the study and Genepro Gen2 for the final 6. These measurements will read in g/dl | 6 weeks per intervention |
Not provided
Not provided
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| David Michael, RN | Musclegen Research, Inc. | Principal Investigator |
| Brian M Parks, PHD | MedFit Rx, Inc. | Study Director |
| Tony R Parks, BS | MedFit Rx, Inc. | Principal Investigator |
Not provided
10 subjects will be administered genepro for the first 6 weeks of the study and whey protein the last 6 week. The other 10 subjects will be administered whey protein for the first 6 weeks of the study and Genepro Gen2 for the last 6 weeks. Weekly blood draws will be taken from each subject to analyze blood protein levels.
Not provided
Not provided
Not provided
Not provided
Not provided
Open call for bariatric patients via social media and direct mail marketing.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Genepro Gen2 Protein Then Whey Protein | 1 tablespoon Serving of Genepro Gen2 Protein daily will be used in each subject. 30g Serving of Whey Isolate Protein will be used daily in each subject. |
| FG001 | Whey Protein Isolate Then Genepro Gen2 Protein | 30g Serving of Whey Isolate Protein will be used daily in each subject. 1 tablespoon Serving of Genepro Gen2 Protein daily will be used in each subject. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
20 Post Op Gastric Bypass patients. 10 men, 10 women. All participants were between the ages of 30-46 years of age. All participants have been post operation from their weight loss surgery for a minimum of 3 months prior to the start of the study and no longer than 12 months at the start of the study.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | All Participants | All participants were given a baseline blood analysis |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Weekly Blood Draws to Measure Blood Protein Levels | Each week the 20 participants will have blood drawn to measure their blood protein levels. Each participant was required to give blood weekly to determine the blood protein levels. The results show the average over each six week period of testing for each row. Each participant was examined to see if they achieved the average range as set fourth by the dieticians of greater than 6.1 and less than 8.7 within a 10% variable as acceptable. 10 Participants will be given Genepro Gen2 for the first six weeks of the study and whey protein for the final 6. 10 Participants will be given when protein for the first six weeks of the study and Genepro Gen2 for the final 6. These measurements will read in g/dl | Posted | Mean | Standard Deviation | grams per deciliter | 6 weeks per intervention |
|
Not provided
No adverse events were monitored
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Genepro Gen2 Protein | 1 tablespoon Serving of Genepro Gen2 Protein daily will be used in each subject. Intervention: Weekly blood draws will determine the effect on blood protein levels. Genepro Protein: weekly blood draws to measure blood protein levels |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| David Michael | Medfit Rx | 9196109893 | dmichael@medfitrx.net |
Not provided
| ID | Term |
|---|---|
| D000067816 | Whey Proteins |
| ID | Term |
|---|---|
| D008894 | Milk Proteins |
| D000080224 | Animal Proteins, Dietary |
| D004044 | Dietary Proteins |
| D011506 | Proteins |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Whey Protein | Dietary Supplement | weekly blood draws to measure blood protein levels |
|
|
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| Protein blood levels | Participants assessed separately for each sequence. | Mean | Standard Deviation | g/dl |
|
| OG001 | Whey Protein Isolate | 30g Serving of Whey Isolate Protein will be used daily in each subject. Intervention: Weekly blood draws will determine the effect on blood protein levels. Whey Protein: weekly blood draws to measure blood protein levels |
|
|
| 0 |
| 0 |
| 0 |
| 0 |
| EG001 | Whey Protein Isolate | 30g Serving of Whey Isolate Protein will be used daily in each subject. Intervention: Weekly blood draws will determine the effect on blood protein levels. Whey Protein: weekly blood draws to measure blood protein levels | 0 | 0 | 0 | 0 |
Not provided
| D000602 |
| Amino Acids, Peptides, and Proteins |
| D000067796 | Whey |
| D008892 | Milk |
| D003611 | Dairy Products |
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D019602 | Food and Beverages |